| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |